gemfibrozil has been researched along with Bone Diseases, Metabolic in 1 studies
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study showed 212 hyperlipidemia with osteopenia patients of which 106 patients in statin group had mean age (63." | 2.75 | Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. ( Chuengsamarn, S; Kaufman, L; Rattanamongkoulgul, S; Suwanwalaikorn, S; Wattanasirichaigoon, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuengsamarn, S | 1 |
| Rattanamongkoulgul, S | 1 |
| Suwanwalaikorn, S | 1 |
| Wattanasirichaigoon, S | 1 |
| Kaufman, L | 1 |
1 trial available for gemfibrozil and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
Topics: Aged; Bone Density; Bone Diseases, Metabolic; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA | 2010 |